INDICATIONS

Citrirex^TM is indicated for the treatment of Pulmonary Arterial Hypertension (PAH) and performance enhancement in healthy adult men and women.

PRESENTATION

Available in 25-milligram quick-dissolving, fast-acting sublingual tablets. Citrirex^TM is packaged in 10 count and 30 count bottles.

DOSAGE & ADMINISTRATION

The recommended starting dose is 25 milligrams (1 tablet), to be taken approximately 15 minutes before physical activity. Based on efficacy and toleration, the dose may be increased to 25 milligrams (1 tablet). The maximum recommended dosage is 25 milligrams (1 tablet). The maximum dose frequency is one dose per day. Citrirex^TM tablets are for oral administration only.

MEDICINE CLASSIFICATION

Citrirex^TM is prescription only and should be taken under the guidance of your medical professional. Keep out of reach of children. Meant only for use in healthy adults over the age of 18. Do not use if pregnant, nursing, or expecting to become pregnant.

*FOR EXPORT ONLY